UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,218 | +33.6% | 21,823 | 0.0% | 0.07% | +39.6% |
| Q2 2023 | $235,143 | +28.6% | 21,823 | 0.0% | 0.05% | +14.3% |
| Q1 2023 | $182,877 | -0.1% | 21,823 | 0.0% | 0.04% | -2.3% |
| Q4 2022 | $183,010 | +2.2% | 21,823 | 0.0% | 0.04% | +4.9% |
| Q3 2022 | $179,000 | +1.1% | 21,823 | 0.0% | 0.04% | +5.1% |
| Q2 2022 | $177,000 | -6.3% | 21,823 | 0.0% | 0.04% | +18.2% |
| Q1 2022 | $189,000 | -9.1% | 21,823 | 0.0% | 0.03% | -2.9% |
| Q4 2021 | $208,000 | -43.3% | 21,823 | 0.0% | 0.03% | -49.3% |
| Q3 2021 | $367,000 | +10.2% | 21,823 | 0.0% | 0.07% | +13.6% |
| Q2 2021 | $333,000 | -21.6% | 21,823 | 0.0% | 0.06% | -33.0% |
| Q1 2021 | $425,000 | +8.1% | 21,823 | 0.0% | 0.09% | +1.1% |
| Q4 2020 | $393,000 | – | 21,823 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |